School of Medicine, Duke University, Durham, North Carolina.
Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.
J Heart Lung Transplant. 2022 Nov;41(11):1628-1637. doi: 10.1016/j.healun.2022.07.015. Epub 2022 Jul 21.
Planned venoarterial extracorporeal membrane oxygenation (VA ECMO) is increasingly used during bilateral orthotopic lung transplantation (BOLT) and may be superior to off-pump support for patients without pulmonary hypertension. In this single-institution study, we compared rates of textbook outcome between BOLTs performed with planned VA ECMO or off-pump support for recipients with no or mild pulmonary hypertension.
Patients with no or mild pulmonary hypertension who underwent isolated BOLT between 1/2017 and 2/2021 with planned off-pump or VA ECMO support were included. Textbook outcome was defined as freedom from intraoperative complication, 30-day reintervention, 30-day readmission, post-transplant length of stay >30 days, 90-day mortality, 30-day acute rejection, grade 3 primary graft dysfunction at 48 or 72 hours, post-transplant ECMO, tracheostomy within 7 days, inpatient dialysis, reintubation, and extubation >48 hours post-transplant. Textbook outcome achievement was compared between groups using multivariable logistic regression.
Two hundred thirty-seven BOLTs were included: 68 planned VA ECMO and 169 planned off-pump. 14 (20.6%) planned VA ECMO and 27 (16.0%) planned off-pump patients achieved textbook outcome. After adjustment for prior BOLT, lung allocation score, ischemic time, and intraoperative transfusions, planned VA ECMO was associated with higher odds of textbook outcome than planned off-pump support (odds ratio 3.89, 95% confidence interval 1.58-9.90, p = 0.004).
At our institution, planned VA ECMO for isolated BOLT was associated with higher odds of textbook outcome than planned off-pump support among patients without pulmonary hypertension. Further investigation in a multi-institutional cohort is warranted to better elucidate the utility of this strategy.
在双侧原位肺移植(BOLT)中,计划进行的静脉-动脉体外膜肺氧合(VA ECMO)的应用越来越多,对于没有肺动脉高压的患者,它可能优于非体外循环支持。在这项单中心研究中,我们比较了在没有或轻度肺动脉高压的受者中,使用计划的 VA ECMO 或非体外循环支持进行 BOLT 时,达到教科书结局的比例。
纳入了 2017 年 1 月至 2021 年 2 月期间接受单纯 BOLT 治疗、计划使用非体外循环或 VA ECMO 支持且没有或轻度肺动脉高压的患者。教科书结局定义为术中无并发症、30 天内再次干预、30 天内再次入院、移植后住院时间>30 天、90 天死亡率、30 天急性排斥反应、48 或 72 小时时 3 级原发性移植物功能障碍、移植后 ECMO、7 天内气管造口术、住院透析、再插管和移植后>48 小时拔管。使用多变量逻辑回归比较两组之间的教科书结局达成情况。
共纳入 237 例 BOLT:68 例计划 VA ECMO 和 169 例计划非体外循环。14 例(20.6%)计划 VA ECMO 和 27 例(16.0%)计划非体外循环患者达到了教科书结局。在校正了先前的 BOLT、肺分配评分、缺血时间和术中输血后,计划 VA ECMO 与计划非体外循环支持相比,达到教科书结局的可能性更高(比值比 3.89,95%置信区间 1.58-9.90,p=0.004)。
在我们的机构中,与计划非体外循环支持相比,在没有肺动脉高压的患者中,计划 VA ECMO 用于单纯 BOLT 与达到教科书结局的可能性更高。需要在多中心队列中进一步研究,以更好地阐明这一策略的实用性。